Tudor Investment Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,301,716
Closed -$34.7M 4128
2025
Q4
$32.4M Buy
1,301,716
+1,120,503
+618% +$28.3M 0.06% 264
2025
Q3
$4.62M Buy
+181,213
New +$4.47M 0.01% 1240
2025
Q2
Sell
-1,156,325
Closed -$27M 3642
2025
Q1
$29.3M Buy
+1,156,325
New +$30.3M 0.1% 130
2024
Q4
Sell
-43,852
Closed -$1.19M 3397
2024
Q3
$1.27M Sell
43,852
-166,123
-79% -$4.85M ﹤0.01% 1481
2024
Q2
$5.88M Buy
+209,975
New +$5.78M 0.03% 597
2024
Q1
Sell
-372,691
Closed -$10.3M 2653
2023
Q4
$10.7M Buy
+372,691
New +$11.3M 0.09% 323
2023
Q3
Sell
-298,246
Closed -$10.5M 2730
2023
Q2
$10.9M Buy
298,246
+195,437
+190% +$7.61M 0.13% 154
2023
Q1
$4.2M Buy
102,809
+86,799
+542% +$3.75M 0.06% 450
2022
Q4
$820K Sell
16,010
-188,949
-92% -$9.06M 0.02% 1247
2022
Q3
$8.97M Buy
+204,959
New +$9.96M 0.19% 99
2022
Q2
Sell
-46,169
Closed -$2.39M 2421
2022
Q1
$2.39M Buy
46,169
+20,243
+78% +$1.05M 0.06% 466
2021
Q4
$1.53M Sell
25,926
-32,143
-55% -$1.59M 0.03% 771
2021
Q3
$2.5M Buy
58,069
+36,332
+167% +$1.61M 0.04% 578
2021
Q2
$851K Sell
21,737
-25,880
-54% -$1.01M 0.02% 930
2021
Q1
$1.73M Buy
47,617
+2,306
+5% +$81.9K 0.03% 587
2020
Q4
$1.67M Sell
45,311
-45,547
-50% -$1.67M 0.05% 489
2020
Q3
$3.16M Buy
90,858
+20,440
+29% +$717K 0.14% 161
2020
Q2
$2.19M Buy
+70,418
New +$2.39M 0.11% 225
2020
Q1
Sell
-166,195
Closed -$6.18M 1253
2019
Q4
$6.18M Buy
166,195
+150,091
+932% +$5.35M 0.28% 65
2019
Q3
$549K Buy
+16,104
New +$586K 0.02% 691
2018
Q3
Sell
-29,754
Closed -$1.02M 1208
2018
Q2
$1.02M Buy
+29,754
New +$1.02M 0.04% 432
2018
Q1
Sell
-26,493
Closed -$910K 1180
2017
Q4
$910K Buy
+26,493
New +$903K 0.02% 380
2017
Q2
Sell
-6,746
Closed -$219K 1292
2017
Q1
$219K Sell
6,746
-4,743
-41% -$150K 0.01% 1183
2016
Q4
$354K Sell
11,489
-6,640
-37% -$203K 0.01% 922
2016
Q3
$583K Sell
18,129
-4,532
-20% -$152K 0.01% 655
2016
Q2
$757K Buy
22,661
+7,273
+47% +$232K 0.02% 583
2016
Q1
$433K Sell
15,388
-21,397
-58% -$611K 0.01% 1054
2015
Q4
$1.13M Buy
36,785
+6,957
+23% +$219K 0.03% 400
2015
Q3
$889K Buy
29,828
+13,386
+81% +$429K 0.03% 434
2015
Q2
$523K Sell
16,442
-1,183,627
-99% -$38.6M 0.02% 747
2015
Q1
$39.6M Buy
1,200,069
+793,752
+195% +$25.2M 1.27% 6
2014
Q4
$12M Buy
406,317
+294,870
+265% +$8.45M 0.42% 32
2014
Q3
$3.13M Buy
111,447
+94,372
+553% +$2.65M 0.11% 99
2014
Q2
$481K Sell
17,075
-905,175
-98% -$25.8M 0.02% 559
2014
Q1
$28.1M Buy
922,250
+873,506
+1,792% +$26M 1.19% 10
2013
Q4
$1.42M Sell
48,744
-952,556
-95% -$27.7M 0.07% 128
2013
Q3
$27.3M Buy
1,001,300
+792,924
+381% +$21.6M 1.12% 11
2013
Q2
$5.54M Buy
+208,376
New +$5.76M 0.42% 58

Other funds holding PFE

Tudor Investment Corp's PFE Position: Q1 2026 in Review

Tudor Investment Corp sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,301,716 shares — an estimated $34.7M sold.

Tudor Investment Corp first reported a position in PFE in Q2 2013 and held it in 38 quarters. The position peaked at $39.6M in Q1 2015. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Tudor Investment Corp reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 1,301,716 Pfizer shares in Q1 2026, an estimated $34.7M.
  • Tudor Investment Corp first reported a position in Pfizer in Q2 2013 and held it in 38 quarters.
  • Tudor Investment Corp's Pfizer position peaked at $39.6M in Q1 2015.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.